MedTrace Logo

Platelet Function in Patients With an Acute Coronary Syndrome

NCT01992484 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2013-11-25

No results posted yet for this study

Summary

The aims of the study are to:

* explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome
* investigate whether a therapeutic window exist for novel platelet inhibitors
* investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario
* investigate the association between genetic polymorphisms, inflammation, platelet reactivity and clinical outcome
* investigate synergistic effects between aspirin and novel platelet inhibitors

Conditions

  • Acute Coronary Syndrome (ACS)

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2015-06-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992484 on ClinicalTrials.gov